The European Journal of Health Economics

Letter from the Editors

How much are health-care systems prepared to pay to produce a QALY?

Martin J. Buxton

Trial-based cost-utility comparison of percutaneous myocardial laser revascularisation and continued medical therapy for treatment of refractory angina pectoris

Helen E. Campbell, Sue Tait, Linda D. Sharples, Noreen Caine, Timothy J. Gray, Peter M. Schofield, Martin J. Buxton

Does testing for prostate-specific antigen contribute to declining prostate cancer mortality?

L. Di Matteo, R. Di Matteo

Indirect costs of cervical and breast cancers in Spain

Juan Oliva, Félix Lobo, Julio López-Bastida, Néboa Zozaya, Rosa Romay

Discrete choice experiments in health economics

Emily Lancsar, Cam Donaldson

Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany

Werner Kulp, J.-M. Graf von der Schulenburg, Wolfgang Greiner

Hospital development plans

Steffen Fleßa

Can economic evaluations be made more transferable?

Stephanie Boulenger, John Nixon, Michael Drummond, Philippe Ulmann, Stephen Rice, Gerard de Pouvourville

Estimating utility data from clinical indicators for patients with stable angina

Louise Longworth, Martin J. Buxton, Mark Sculpher, David H. Smith

The cost-effectiveness of dual oral antiplatelet therapy following percutaneous coronary intervention

Anna Ringborg, Peter Lindgren, Bengt Jönsson